Australian government commits $35 million for dementia research

7 August 2015 - The Australian government have announced they will invest AUS$35.6 million into six Dementia Research Team Grants, as part of their ongoing commitment to support and promote research into care, treatments and risk reduction for dementia.

One of the six grants will be used to develop the largest clinical trial in the world for people aged 55-75, testing an online tool to help reduce the risk of dementia. This work will be led by Professor Henry Brodaty, Co-Director of CHeBA (Centre for Healthy Brain Ageing) and ADI Honorary Vice President.

It has also been announced that Alzheimer's Australia will establish and run Australia's National Institute for Dementia Research, which will focus on a quicker translation of evidence from paper to policy and practice, as well as aligning the work of the institute with research being undertaken internationally.

Glenn Rees, Chair of ADI and former CEO of Alzheimer’s Australia commented; "This is a unique opportunity to prioritise the direction of dementia research and to foster collaboration between researchers, industry and consumers. I congratulate Alzheimer’s Australia on the partnership role they are to play with the National Health and Medical Research Council in establishing the Institute."

Where next?